SCIENTURE HOLDINGS, INC. Proceeds from (Repayments of) Debt
SCIENTURE HOLDINGS, INC. (SCNX) reported Proceeds from (Repayments of) Debt of $1.60 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. proceeds from (repayments of) debt for the quarter ending 2025-09-30 was $1.60M.
- SCIENTURE HOLDINGS, INC. proceeds from (repayments of) debt for the quarter ending 2025-03-31 was $1.60M.
| Period end | Proceeds from (Repayments of) Debt 3 month | Proceeds from (Repayments of) Debt 9 month |
|---|---|---|
| 2025-09-30 | $1.60M 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $1.60M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $25.00K 10-Q · filed 2024-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |